Inquiry Basket
Loading ......
Pneumonia virus refers to a group of different viral pathogens that can infect the lower respiratory tract and cause inflammation of the lung parenchyma, known as viral pneumonia. The scope of this disease ranges from mild, self limiting illnesses to severe, life-threatening illnesses, especially in very young, elderly, and immunocompromised populations. Unlike bacterial pneumonia, viral pneumonia typically has different pathological features and requires different management strategies. The clinical environment is mainly dominated by several key viruses, including influenza virus, respiratory syncytial virus (RSV), adenovirus, severe acute respiratory syndrome coronavirus type 2, and parainfluenza virus (PIV).
Figure 1. Inflammatory and oxidative stress mechanisms in the infectious process of viral pneumonia. (Tie Y,et al, 2025)
The severity of viral pneumonia depends not only on virus replication, but also on the host's immune response. Dysregulated or excessive inflammatory responses often lead to severe tissue damage and clinical deterioration. The study of multiple respiratory viruses has identified common host pathways and genes that are crucial for this pathological process. The following table summarizes the key host factors and pathways involved in the pathogenesis of severe viral pneumonia:
| Host Factor / Gene | Associated Pathway / Process | Function in Pathogenesis |
| CMPK2 (Cytidine/uridine monophosphate kinase 2) | NLRP3 Inflammasome Activation | A central hub gene upregulated by multiple respiratory viruses (RSV, rhinovirus, influenza, SARS-CoV-2). It activates the NLRP3 inflammasome, leading to the release of potent pro-inflammatory cytokines IL-1β and IL-18, driving severe pneumonia. |
| NLRP3 Inflammasome | Pyroptosis & Inflammation | A multi-protein complex whose activation is a common mechanism in severe pneumonia. It cleaves pro-IL-1β and pro-IL-18 into their active forms and triggers an inflammatory form of programmed cell death called pyroptosis. |
| NF-κB, MAPK, TNF pathways | Pro-inflammatory Signaling | Core signaling pathways rapidly activated upon viral detection. They coordinate the expression of numerous inflammatory mediators (cytokines, chemokines). Excessive or prolonged activation is linked to detrimental "cytokine storm" pathology. |
| RIPK1, RIPK3 | Necroptosis | Mediate an alternative form of programmed cell death. Activated by certain viral infections or bacterial toxins, necroptosis can contribute to inflammation and tissue damage in the lung. |
Viral pneumonia is a lung inflammation caused by upper respiratory tract viral infection and downward spread. This disease can occur all year round, but it is mostly seen in winter and spring, and can break out or spread sporadically. The main clinical manifestations include fever, headache, body aches, dry cough, and lung infiltration. The occurrence of viral pneumonia is related to the virulence of the virus, the route of infection, as well as the age and immune status of the host. Generally, the incidence rate of children is higher than that of adults.
In acute respiratory infections, viral infections account for 90%, and viral infections are mainly in the upper respiratory tract, including common cold, pharyngitis, laryngotracheitis bronchitis, bronchiolitis, infantile herpetic pharyngitis, and influenza chest pain. The viruses that cause pneumonia are rare, among which influenza virus is the most common, and other viruses are parainfluenza virus, cytomegalovirus, adenovirus, rhinovirus, coronavirus and some enteroviruses, such as coxsackie virus, echo virus, and herpes simplex, varicella zoster, rubella, measles and other viruses. Infants and young children often develop pneumonia from respiratory syncytial virus infection. Viral pneumonia often occurs in winter and spring seasons, and can spread or erupt. In non bacterial pneumonia, viral infection accounts for 25% to 50%, and patients are mostly children, with relatively less incidence in adults.
| Diagnosis | Details |
| Pathogenic examination | Virus cultivation is difficult and not easily carried out routinely. Sputum smears of pneumonia patients only show scattered bacteria and a large number of nucleated cells, or no pathogenic bacteria can be found. The possibility of viral pneumonia should be suspected. |
| Serological examination | Double serum samples from the acute and recovery phases, as well as complement binding test, neutralization test, or serum suppression test, with antibody titers increased by 4 times or more, have diagnostic significance. In recent years, using serum to monitor virus specific IgM antibodies has been helpful for early diagnosis. Immunofluorescence, enzyme-linked immunosorbent assay, enzyme-linked immunosorbent assay, enzyme-linked immunosorbent assay, horseradish peroxidase anti horseradish peroxidase method, etc. can be used for rapid diagnosis of virus specificity. |
| White blood cells | The count is normal, slightly high or low, and the erythrocyte sedimentation rate is usually within the normal range. The white blood cells seen in sputum smears are mostly monocytes, and there is often no growth of pathogenic bacteria in sputum culture. |
| Chest X-ray | Examination shows increased lung texture, small patchy infiltration or extensive infiltration. In severe cases, diffuse nodular infiltration is observed in both lungs, but lobar consolidation and pleural effusion are not commonly seen. The pathogenic factors of viral pneumonia are different, and their X-ray signs also have different characteristics. |
Both PY and SV40 virus particles have a 20 sided stereosymmetric structure, with the same diameter, number of capsids, and DNA molecular weight, but with differences in protein composition SV40DNA contains 5243 base pairs, while PY virus is a circular double stranded DNA molecule composed of 5292 base pairs The isolated and purified viral DNA is infectious and can transform cells and induce tumors in hamsters in vitro A detailed study has been conducted on the structure of the SV40 virus, with a clear understanding of its genome nucleotide sequence analysis, gene localization, and various proteins involved in replication. The SV40 virus genome is divided into 100 equal parts using the EcoRl endonuclease cleavage site as the 0 point, and the Ori point is the starting point for bidirectional DNA replication The early coding process within the SV40 virus genome is counterclockwise, and the encoded proteins (large T and small T antigens) are related to inducing host cell transformation before viral DNA production. The late coding region process is clockwise and encodes three viral capsid proteins, VP1, VP2, and CP3, after the start of viral DNA replication. These proteins are structural proteins of the virus and do not participate in the process of cell transformation The physical structure diagram of PY is similar to SV40, which is also a circular structure, but the origin of ori is different, and the early coding process is clockwise, encoding three proteins (large T, medium T, and small T antigens).
Targeted treatment should be the main approach, bed rest should be taken, air circulation should be maintained in the living room, and attention should be paid to isolation and disinfection to prevent cross infection. Provide sufficient vitamins and protein, drink plenty of water and consume soft foods in small amounts multiple times, and administer intravenous fluids and oxygen as appropriate. Keep the respiratory tract unobstructed and promptly remove upper respiratory secretions, etc. In principle, antibiotics should not be used to prevent secondary bacterial infections. Once it is confirmed that a combined bacterial infection has occurred, sensitive antibiotics should be selected in a timely manner.
Viral pneumonia is a major global health challenge caused by a range of pathogens. Its pathogenesis is a double-edged sword, involving direct viral cytotoxicity and, more importantly, the host's own immune response. Identifying common pathological pathways, such as inflammasome activation driven by factors such as CMPK2, has opened up new avenues for host directed therapies aimed at alleviating immunopathology. Continuing to study these sharing mechanisms is crucial for developing better strategies to manage and prevent serious disease outcomes.
Reference
| Target | Cat. No. | Product Name | Host | Isotype | Application | |
| Mouse Pneumonia Virus NP | DPAB-CS24694 | Rabbit Anti-Mouse Pneumonia Virus NP Polyclonal antibody | Rabbit | IgG | ELISA, WB | Inquiry |
| Target | Cat. No. | Product Name | Host | |
| PVM | DAG-WT5880 | Pneumonia Virus of mice (PVM) Stock (Qualitative) | N/A | Inquiry |
| DAG-WT1153 | Pneumonia Virus of Mice (PVM) Positive Control | N/A | Inquiry | |
| DAG-WT1148 | Native Pneumonia Virus of Mice | N/A | Inquiry |
Loading ......
